Sanomedics International Holdings’ (SIMH) primary mission is to significantly improve the quality of life for patients and the physicians who treat them through an innovative thought processes which creates value for our customers and shareholders.
SIMH is a public medical technology company dedicated to the identification, creation and development of new medical technology solutions. SIMH creates and seeks out new ideas which match certain key fundamental criteria and then add capital, intellectual property, and expertise in the fields of clinical, engineering, legal, strategic marketing, and financing, while focusing on efficient and timely development.
Sanomedics International Holdings’ (SIMH) primary mission is to significantly improve the quality of life for patients and the physicians who treat them through an innovative thought processes which creates value for our customers and shareholders.
Our Team:
- Craig Sizer Co-Founder and Chairman
- Keith Houlihan Co-Founder and President
- Gary O’Hara Chief Technology Officer
- Steve Relis Chief Financial Officer
Advisory Board Members:
